HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margarida Borges Selected Research

Margarida Borges Research Topics

Disease

8Infections
01/2021 - 11/2004
3Atrial Fibrillation
01/2022 - 01/2015
3Granuloma
11/2019 - 08/2015
3Pneumococcal Infections
01/2019 - 07/2011
3Breast Neoplasms (Breast Cancer)
11/2013 - 07/2008
2Atrophy
01/2021 - 10/2012
2Coronary Disease (Coronary Heart Disease)
01/2021 - 01/2004
2Heart Failure
01/2021 - 04/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2004
2Necrosis
01/2020 - 09/2015
2Myocardial Infarction
12/2015 - 01/2015
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2021
1Toxoplasmosis
01/2020
1Inflammation (Inflammations)
01/2020
1Pneumonia (Pneumonitis)
01/2020
1Congenital Toxoplasmosis
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Communicable Diseases (Infectious Diseases)
11/2019
1Pneumococcal Pneumonia
01/2019
1Tuberculosis (Tuberculoses)
12/2017
1Hemorrhage
12/2015
1Ischemic Stroke
12/2015
1Hypoxia (Hypoxemia)
09/2015
1Unstable Angina
01/2015
1Acute Coronary Syndrome
01/2015
1Neoplasms (Cancer)
11/2013
1Human Influenza (Influenza)
07/2011
1Drug Resistant Epilepsy
07/2011
1Partial Epilepsies (Epilepsy, Partial)
07/2011
1Lymphopenia (Lymphocytopenia)
01/2011
1Chronic Kidney Failure (Chronic Renal Failure)
01/2011
1Diabetes Mellitus
05/2006
1Hypercholesterolemia
01/2004
1Disease Progression
01/2001
1Parasitic Diseases (Parasitic Disease)
01/2001

Drug/Important Bio-Agent (IBA)

3VaccinesIBA
01/2020 - 07/2011
3LipidsIBA
12/2017 - 01/2004
3Aromatase InhibitorsIBA
11/2013 - 07/2008
3Aromatase (CYP19)IBA
11/2013 - 07/2008
223-valent pneumococcal capsular polysaccharide vaccineIBA
01/2021 - 01/2019
2Interferon-gamma (Interferon, gamma)IBA
01/2021 - 06/2005
2TamoxifenFDA LinkGeneric
11/2013 - 07/2008
2Hormones (Hormone)IBA
11/2013 - 01/2012
2Estrogens (Estrogen)FDA Link
01/2012 - 07/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021
1GlucocorticoidsIBA
01/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1sacubitril and valsartan sodium hydrate drug combinationIBA
04/2020
1EnalaprilFDA LinkGeneric
04/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1Bronchodilator Agents (Bronchodilators)IBA
01/2020
1GoldIBA
01/2020
1ProgesteroneFDA LinkGeneric
01/2020
1Subunit VaccinesIBA
01/2020
1CytokinesIBA
11/2019
1Conjugate VaccinesIBA
01/2019
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
01/2019
1Lipid NanoparticlesIBA
12/2017
1Rifampin (Rifampicin)FDA LinkGeneric
12/2017
1AnticoagulantsIBA
12/2015
1DabigatranFDA Link
12/2015
1Warfarin (Coumadin)FDA LinkGeneric
12/2015
1Vitamin KFDA Link
12/2015
1RivaroxabanIBA
12/2015
1apixabanIBA
12/2015
1Transcription Factors (Transcription Factor)IBA
09/2015
1Muramidase (Lysozyme)IBA
09/2015
1Glucose (Dextrose)FDA LinkGeneric
08/2015
1InterferonsIBA
08/2015
1TicagrelorIBA
01/2015
1Estrogen ReceptorsIBA
11/2013
1CorticosteroneIBA
10/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2012
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
10/2012
1AndrogensIBA
01/2012
1Biological ProductsIBA
01/2012
1exemestane (Aromasin)FDA Link
01/2012
1Anticonvulsants (Antiepileptic Drugs)IBA
07/2011
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2008
1Pharmaceutical PreparationsIBA
05/2006
14-1BB Ligand (4 1BB Ligand)IBA
11/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2004
1Monoclonal AntibodiesIBA
11/2004
1CD27 LigandIBA
11/2004
1OX40 LigandIBA
11/2004
1CD30 LigandIBA
11/2004
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2004
1CholesterolIBA
01/2004
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2004
1HDL LipoproteinsIBA
01/2004
1AntigensIBA
01/2001
1MitogensIBA
01/2001
1Virulence Factors (Pathogenicity Factors)IBA
01/2001

Therapy/Procedure

3Therapeutics
01/2022 - 01/2011
3Secondary Prevention
01/2015 - 01/2004
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2015
1Ambulatory Care (Outpatient Care)
01/2015
1Percutaneous Coronary Intervention
01/2015
1Renal Dialysis (Hemodialysis)
01/2011